Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects

CC Sheu, SY Lin, YT Chang, CY Lee… - Expert Review of Anti …, 2018 - Taylor & Francis
… have brought the issue of ESBL infections into the spotlight. Despite many efforts, there
are remaining controversies regarding the detection and management of ESBL infections. …

Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymes

PNA Harris - Seminars in respiratory and critical care medicine, 2015 - thieme-connect.com
… , host range, and spectrum of activity of β-lactamases. This has been most clearly reflected
by the marked increase in infections caused by bacteria that express extended-spectrum β-…

[PDF][PDF] Diagnosis and Management of Infections Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamase

A Amelia, A Nugroho, PN Harijanto - hospital, 2016 - core.ac.uk
… Diagnosis and management of ESBL-E infection have become more and more challenging
due … -E infections, with a focus on diagnosis and management of such infection by reviewing …

Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …

PD Tamma, SL Aitken, RA Bonomo… - Clinical Infectious …, 2021 - academic.oup.com
… documents for the treatment of specific infectious processes. Guidance documents address
specific clinical questions for difficult-to-manage infections that are not covered by present …

… of bloodstream infections with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management …

RJ Cordery, CH Roberts, SJ Cooper… - … of Hospital Infection, 2008 - Elsevier
Controlled studies that address risk factors for, and clinical outcomes after, infection with
extended-spectrum β-lactamase (ESBL)-producing organisms are scant, particularly in the …

Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option

JM Blondeau - Drugs, 2004 - Springer
… [8,9] The clinical manageenced by patients are often underappreciated by ment guidelines
developed by the Infectious Disphysicians, leading to the use of inadequate thera- eases …

Long-term clinical and economic benefits associated with the management of a nosocomial outbreak resulting from extended-spectrum beta-lactamase-producing …

E Piednoir, P Thibon, GC Borderan, F Godde… - Critical care …, 2011 - journals.lww.com
… was an epidemic of infections resulting from extended-spectrum β-… Consequences of inaction
in the infection control field have … in the infectious risk management practices are scarce. …

Extended-spectrum β-lactamases: a clinical update

DL Paterson, RA Bonomo - Clinical microbiology reviews, 2005 - Am Soc Microbiol
… appropriate infection control interventions. Endemic transmission of ESBL producers can
also be curtailed using infection control measures and antibiotic management interventions. …

[HTML][HTML] Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?

ZD Pana, T Zaoutis - F1000Research, 2018 - ncbi.nlm.nih.gov
The spread of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE)
has dramatically increased worldwide, and this “evolving crisis” is currently regarded …

[HTML][HTML] Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese …

X Guan, L He, B Hu, J Hu, X Huang, G Lai, Y Li… - … and Infection, 2016 - Elsevier
… diagnosis, clinical management and infection control of XDR-GNB infections. Lists of … -GNB
infections are analyzed, with long-term exposure to extended-spectrum antimicrobials …